Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0002076327-26-000002

Options or other derivatives

  • Chief Scientific Officer acquired 430,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kolbeck Roland Wilhelm · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-02 Grant or award : show line 1 in the form Restricted Stock Units +95,700 95,700 D
2026-02-02 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +334,900 334,900 D
Loading xslF345X05/form4-02062026_110219.xml…